Picture of UCB SA logo

UCB UCB SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: UCB Says Got Positive CHMP Opinion For New Zilbrysq Pre-Filled Pen In EU

March 26 (Reuters) - Ucb SA UCB.BR:

UCB RECEIVES POSITIVE CHMP OPINION FOR NEW ZILBRYSQ (ZILUCOPLAN) PRE-FILLED PEN IN EU FOR ADULTS LIVING WITH GENERALIZED MYASTHENIA GRAVIS

FIRST ONCE-DAILY SUBCUTANEOUS C5 INHIBITOR AVAILABLE AS PRE-FILLED PEN IN EUROPE AS ADD-ON TO STANDARD THERAPY FOR TREATMENT OF GMG IN ADULT PATIENTS WHO ARE ANTI-ACETYLCHOLINE RECEPTOR (ACHR) ANTIBODY POSITIVE

Source text: https://tinyurl.com/4ysfc32z

Further company coverage: UCB.BR

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on UCB SA

See all news